scorecardresearch
Add as a preferred source on Google
Tuesday, March 10, 2026
TopicDCGI

Topic: DCGI

No local clinical trial waiver despite change in rules, drugmakers knock on health ministry’s door

Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved in select countries by means of local clinical trials waiver.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

‘Unauthorised promotion’, risk of unsafe use: Why CDSCO revoked nod for eye drops to replace glasses

Drugs Controller General of India, who heads CDSCO, says Entod pharma failed to reply satisfactorily to queries raised. Entod to challenge suspension of approval.

Why apex ophthalmologists’ body wants to review new eye drops designed to replace reading glasses

All India Ophthalmological Society has set up expert group to review PresVu & develop guidelines on side-effects, keeping in mind 'potential inappropriate marketing, indiscriminate use'.

Launched in India: eye drop that can replace your reading glasses

Launched Tuesday by Entod Pharmaceuticals under brand name PresVu, eye drop will treat presbyopia, an age-related condition causing blurry vision. To be available across India by October.

Govt notifies rule for rapid launch of breakthrough drugs in India, bypassing local clinical trials

In an executive order, the DGCI has specified a list of countries under rule 101 of New Drugs and Clinical Trials Rules, 2019. List includes US, UK & EU, among others.

Breakthrough cancer treatment to be available in India 1st time as CAR-T cell therapy gets DCGI nod

Therapy developed by IIT-Bombay spin-off company ImmunoACT approved for relapsed-refractory B-cell lymphoma, leukemia, to be available in around 20 govt & pvt hospitals across major cities.

Calls for caution over phenylephrine’s efficacy, as FDA panel deems decongestant ineffective

Panel report notes that oral phenylephrine is no better than placebo for relieving nasal congestion. In India, phenylephrine is widely used in cough and cold medicines.

Kerala doctors & researchers plan India’s 1st private drug quality assessment drive

Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.

After WHO alert, drug controller general warns against use of cough syrups containing pholcodine

Pholcodine is used to treat dry cough. WHO had flagged risk of anaphylactic reactions in those who took remedies containing Pholcodine at least 12 months prior to surgery.

On Camera

The oil pipelines that could decide the Iran war

Washington: Iran’s strategy in its war with the US and Israel is by now clear: Impose an intolerable economic cost on President Donald Trump,...

Russian crude never left India’s import mix. It made up 1/3rd of oil imports from 2024 to 2026

After dominating India’s crude imports since 2023, Russian supplies slowed amid US sanctions, but a 30-day ‘waiver’ amid West Asia tensions could now push flows back towards 2 mbpd.

India and Indonesia finalise BrahMos deal, contract to be signed early next fiscal

One battery of the BrahMos missile is to be procured in the initial phase. The plan is to scale up the procurement in phases.

Trump brings the Age of Humiliation for friends. Modi needs stoicism abroad, humility at home

Trump has ushered in the age of humiliation. His method is to push around America’s friends rudely and publicly. He knows none of them can afford to fight back.